Mechanisms of pericyte recruitment in tumour angiogenesis: A new role for metalloproteinases

Gerhardt, 2003, Endothelial–pericyte interactions in angiogenesis, Cell Tissue Res, 314, 15, 10.1007/s00441-003-0745-x Farrington-Rock, 2004, Chondrogenic and adipogenic potential of microvascular pericytes, Circulation, 110, 2226, 10.1161/01.CIR.0000144457.55518.E5 Courtoy, 1983, Fibronectin in the microvasculature: localization in the pericyte–endothelial interstitium, J Ultrastruct Res, 83, 258, 10.1016/S0022-5320(83)90133-8 Jain, 2003, Molecular regulation of vessel maturation, Nat Med, 9, 685, 10.1038/nm0603-685 Carmeliet, 2003, Angiogenesis in health and disease, Nat Med, 9, 653, 10.1038/nm0603-653 Carmeliet, 2000, Angiogenesis in cancer and other diseases, Nature, 407, 249, 10.1038/35025220 Eberhard, 2000, Heterogeneity of angiogenesis and blood vessel maturation in human tumors implications for antiangiogenic tumor therapies, Cancer Res, 60, 1388 Nielsen, 1997, Expression of matrix metalloprotease-9 in vascular pericytes in human breast cancer, Lab Invest, 77, 345 Bergers, 2003, Benefits of targeting both pericytes and endothelial cells in the tumor vasculature with kinase inhibitors, J Clin Invest, 111, 1287, 10.1172/JCI200317929 Chantrain, 2004, Stromal matrix metalloproteinase-9 regulates the vascular architecture in neuroblastoma by promoting pericyte recruitment, Cancer Res, 64, 1675, 10.1158/0008-5472.CAN-03-0160 Spurbeck, 2002, Enforced expression of tissue inhibitor of matrix metalloproteinase-3 affects functional capillary morphogenesis and inhibits tumor growth in a murine tumor model, Blood, 100, 3361, 10.1182/blood.V100.9.3361 Feron, 2004, Targeting the tumor vascular compartment to improve conventional cancer therapy, Trends Pharmacol Sci, 25, 536, 10.1016/j.tips.2004.08.008 Morikawa, 2002, Abnormalities in pericytes on blood vessels and endothelial sprouts in tumors, Am J Pathol, 160, 985, 10.1016/S0002-9440(10)64920-6 Jodele, 2005, The contribution of bone marrow-derived cells to the tumor vasculature in neuroblastoma is matrix metalloproteinase-9 dependent, Cancer Res, 65, 3200, 10.1158/0008-5472.CAN-04-3770 Gee, 2003, Tumor vessel development and maturation impose limits on the effectiveness of anti-vascular therapy, Am J Pathol, 162, 183, 10.1016/S0002-9440(10)63809-6 Reinmuth, 2001, Induction of VEGF in perivascular cells defines a potential paracrine mechanism for endothelial cell survival, FASEB J, 15, 1239, 10.1096/fj.00-0693fje Benjamin, 1999, Selective ablation of immature blood vessels in established human tumors follows vascular endothelial growth factor withdrawal, J Clin Invest, 103, 159, 10.1172/JCI5028 Erber, 2004, Combined inhibition of VEGF and PDGF signalling enforces tumor vessel regression by interfering with pericyte-mediated endothelial cell survival mechanisms, FASEB J, 18, 338, 10.1096/fj.03-0271fje Ozerdem, 2003, Early contribution of pericytes to angiogenic sprouting and tube formation, Angiogenesis, 6, 241, 10.1023/B:AGEN.0000021401.58039.a9 Lindahl, 1997, Pericyte loss and microaneurysm formation in PDGF-B-deficient mice, Science, 277, 242, 10.1126/science.277.5323.242 Spiegel, 2003, Sphingosine-1-phosphate: an enigmatic signalling lipid, Nat Rev Mol Cell Biol, 4, 397, 10.1038/nrm1103 Loughna, 2001, Angiopoietin and Tie signalling pathways in vascular development, Matrix Biology, 20, 319, 10.1016/S0945-053X(01)00149-4 Iivanainen, 2003, Angiopoietin-regulated recruitment of vascular smooth muscle cells by endothelial-derived heparin binding EGF-like growth factor, FASEB J, 17, 1609, 10.1096/fj.02-0939com Benson, 2004, Role of transforming growth factor beta in breast carcinogenesis, Lancet Oncol, 5, 229, 10.1016/S1470-2045(04)01426-3 Abramsson, 2003, Endothelial and nonendothelial sources of PDGF-B regulate pericyte recruitment and influence vascular pattern formation in tumors, J Clin Invest, 112, 1142, 10.1172/JCI200318549 Guo, 2003, Platelet-derived growth factor-B enhances glioma angiogenesis by stimulating vascular endothelial growth factor expression in tumor endothelia and by promoting pericyte recruitment, Am J Pathol, 162, 1083, 10.1016/S0002-9440(10)63905-3 Chae, 2004, Requirement for sphingosine 1-phosphate receptor-1 in tumor angiogenesis demonstrated by in vivo RNA interference, J Clin Invest, 114, 1082, 10.1172/JCI200422716 Metheny-Barlow, 2003, The enigmatic role of angiopoietin-1 in tumor angiogenesis, Cell Res, 13, 309, 10.1038/sj.cr.7290176 Machein, 2004, Angiopoietin-1 promotes tumor angiogenesis in a rat glioma model, Am J Pathol, 165, 1557, 10.1016/S0002-9440(10)63413-X Ahmad, 2001, The effects of angiopoietin-1 and -2 on tumor growth and angiogenesis in human colon cancer, Cancer Res, 61, 1255 Stoeltzing, 2003, Angiopoietin-1 inhibits vascular permeability, angiogenesis, and growth of hepatic colon cancer tumors, Cancer Res, 63, 3370 Akhurst, 2001, TGF-beta signalling in cancer – a double-edged sword, Trends Cell Biol, 11, S44 Tuxhorn, 2002, Inhibition of transforming growth factor-beta activity decreases angiogenesis in a human prostate cancer-reactive stroma xenograft model, Cancer Res, 62, 6021 Forsyth, 1999, Gelatinase-A (MMP-2), gelatinase-B (MMP-9) and membrane type matrix metalloproteinase-1 (MT1-MMP) are involved in different aspects of the pathophysiology of malignant gliomas, Br J Cancer, 79, 1828, 10.1038/sj.bjc.6690291 Lehti, 2005, An MT1-MMP-PDGF receptor-beta axis regulates mural cell investment of the microvasculature, Genes Dev, 19, 979, 10.1101/gad.1294605 Girolamo, 2004, Involvement of metalloprotease-2 in the development of human brain microvessels, Histochem Cell Biol, 122, 261, 10.1007/s00418-004-0705-x Wang, 1998, Vascular endothelial growth factor upregulates the expression of matrix metalloproteinases in vascular smooth muscle cells: role of flt-1, Circ Res, 83, 832, 10.1161/01.RES.83.8.832 Cho, 2002, Matrix metalloproteinase-9 is necessary for the regulation of smooth muscle cell replication and migration after arterial injury, Circ Res, 91, 845, 10.1161/01.RES.0000040420.17366.2E Arihiro, 2001, Vascular smooth muscle cells and pericytes express MMP-1, MMP-9, TIMP-1 and type I procollagen in inflammatory bowel disease, Histopathology, 39, 50, 10.1046/j.1365-2559.2001.01142.x Wolf, 2003, Compensation mechanism in tumor cell migration: mesenchymal-amoeboid transition after blocking of pericellular proteolysis, J Cell Biol, 160, 267, 10.1083/jcb.200209006 Pauly, 1994, Migration of cultured vascular smooth muscle cells through a basement membrane barrier requires type IV collagenase activity and is inhibited by cellular differentiation, Circ Res, 75, 41, 10.1161/01.RES.75.1.41 Zempo, 1996, Regulation of vascular smooth muscle cell migration and proliferation in vitro and in injured rat arteries by a synthetic matrix metalloproteinase inhibitor, Arterioscler Thromb Vasc Biol, 16, 28, 10.1161/01.ATV.16.1.28 Baker, 1998, Divergent effects of tissue inhibitor of metalloproteinase-1, -2, or -3 overexpression on rat vascular smooth muscle cell invasion, proliferation, and death in vitro. TIMP-3 promotes apoptosis, J Clin Invest, 101, 1478, 10.1172/JCI1584 Guo, 2004, Tissue inhibitor of metalloproteinases-4 suppresses vascular smooth muscle cell migration and induces cell apoptosis, Life Sci, 75, 2483, 10.1016/j.lfs.2004.07.007 Henriet, 2000, Contact with fibrillar collagen inhibits melanoma cell proliferation by up-regulating p27 KIP1, Proc Natl Acad Sci USA, 97, 100026, 10.1073/pnas.170290997 Bond, 2004, Focal adhesion kinase (FAK)-dependent regulation of S-phase kinase-associated protein-2 (Skp-2) stability. A novel mechanism regulating smooth muscle cell proliferation, J Biol Chem, 279, 37304, 10.1074/jbc.M404307200 Grant, 1998, Fibronectin fragments modulate human retinal capillary cell proliferation and migration, Diabetes, 47, 1335, 10.2337/diabetes.47.8.1335 Petitclerc, 1999, Integrin alpha (v)beta3 promotes M21 melanoma growth in human skin by regulating tumor cell survival, Cancer Res, 59, 2724 Boulay, 2001, High cancer cell death in syngeneic tumors developed in host mice deficient for the stromelysin-3 matrix metalloproteinase, Cancer Res, 61, 2189 Uglow, 2003, Dismantling of cadherin-mediated cell–cell contacts modulates smooth muscle cell proliferation, Circ Res, 92, 1314, 10.1161/01.RES.0000079027.44309.53 Bergers, 2000, Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis, Nat Cell Biol, 2, 737, 10.1038/35036374 Huang, 2002, Contributions of stromal metalloproteinase-9 to angiogenesis and growth of human ovarian carcinoma in mice, J Natl Cancer Inst, 94, 1134, 10.1093/jnci/94.15.1134 Imai, 1997, Degradation of decorin by matrix metalloproteinases: identification of the cleavage sites, kinetic analyses and transforming growth factor-beta1 release, Biochem J, 322, 809, 10.1042/bj3220809 Tanimoto, 2004, Sphingosine 1-phosphate transactivates the platelet-derived growth factor beta receptor and epidermal growth factor receptor in vascular smooth muscle cells, Circ Res, 94, 1050, 10.1161/01.RES.0000126404.41421.BE Eguchi, 2001, Activation of MAPKs by angiotensin II in vascular smooth muscle cells. Metalloprotease-dependent EGF receptor activation is required for activation of ERK and p38 MAPK but not for JNK, J Biol Chem, 276, 7957, 10.1074/jbc.M008570200 Prenzel, 1999, EGF receptor transactivation by G-protein-coupled receptors requires metalloproteinase cleavage of proHB-EGF, Nature, 402, 884, 10.1038/47260 Langlois, 2004, Membrane type 1-matrix metalloproteinase (MT1-MMP) cooperates with sphingosine 1-phosphate to induce endothelial cell migration and morphogenic differentiation, Blood, 103, 3020, 10.1182/blood-2003-08-2968 Suzuki, 1997, Matrix metalloproteinase-3 releases active heparin-binding EGF-like growth factor by cleavage at a specific juxtamembrane site, J Biol Chem, 272, 31730, 10.1074/jbc.272.50.31730 Yu, 2002, CD44 anchors the assembly of matrilysin/MMP-7 with heparin-binding epidermal growth factor precursor and ErbB4 and regulates female reproductive organ remodeling, Genes Dev, 16, 307, 10.1101/gad.925702 Lucchesi, 2004, Involvement of metalloproteinases 2/9 in epidermal growth factor receptor transactivation in pressure-induced myogenic tone in mouse mesenteric resistance arteries, Circulation, 110, 3587, 10.1161/01.CIR.0000148780.36121.47 Roelle, 2003, Matrix metalloproteinases 2 and 9 mediate epidermal growth factor receptor transactivation by gonadotropin-releasing hormone, J Biol Chem, 278, 47307, 10.1074/jbc.M304377200 Heissig, 2002, Recruitment of stem and progenitor cells from the bone marrow niche requires MMP-9 mediated release of kit-ligand, Cell, 109, 625, 10.1016/S0092-8674(02)00754-7 Yamashita, 2000, Flk1-positive cells derived from embryonic stem cells serve as vascular progenitors, Nature, 408, 92, 10.1038/35040568 Rajantie, 2004, Adult bone marrow-derived cells recruited during angiogenesis comprise precursors for periendothelial vascular mural cells, Blood, 104, 2084, 10.1182/blood-2004-01-0336 Berger, 2005, Regulator of G-protein signalling-5 induction in pericytes coincides with active vessel remodeling during neovascularization, Blood, 105, 1094, 10.1182/blood-2004-06-2315